Digoxin Is Associated With Increased Shock Events and Electrical Storms in Patients With Implantable Cardioverter Defibrillators.

George S MinaMadan AcharyaTaylor ShepherdGeorge GobrialMichael TekesteHussam WattiRuchi BhandariAditya SainiPratap ReddyPaari Dominic

Published in: Journal of cardiovascular pharmacology and therapeutics (2017)

Digoxin is associated with increased shock events and electrical storms in patients with ICDs; however, large randomized controlled studies are needed to confirm our findings.

Keyphrases

double blind
open label
phase iii
phase ii
clinical trial
case control
heart failure
study protocol